Notably, it merely blocks the metabolic activity of PKM2 rather than that of PKM1, making it a promising PKM2 inhibitor for the prevention of colorectal cancer (CRC) (Yang et al., 2018). The gene discussed is PKM; the disease is colorectal carcinoma.